By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS








Company News
Soligenix (SNGX) Reports Second Quarter 2014 Financial Results, And Highlights Recent Accomplishments 8/11/2014 8:42:53 AM
Soligenix (SNGX) Advances Development Of A Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™ 8/7/2014 8:09:53 AM
Soligenix (SNGX) Advances Development Of A Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™ 8/7/2014 8:06:42 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of OrbeShield™ In GI ARS 8/1/2014 7:14:57 AM
Soligenix (SNGX) Announces Combination Vaccine For Ricin And Anthrax Achieves Simultaneous Protection 7/9/2014 10:01:59 AM
Soligenix (SNGX) Reports First Quarter 2014 Financial Results, And Highlights Recent Accomplishments 5/12/2014 6:12:35 AM
Soligenix (SNGX) Announces $200,000 NIDCR SBIR Grant Award Supporting Phase 2 Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer 4/7/2014 9:58:01 AM
Soligenix (SNGX) Reports Year-End 2013 Financial Results And Highlights Recent Accomplishments 3/26/2014 6:23:46 AM
Vista Partners Initiates Coverage On Soligenix (SNGX); $5.50 Price Target 3/19/2014 9:46:32 AM
Soligenix (SNGX.OB) To Present At 2014 World Vaccine Congress In Washington, DC 3/11/2014 6:19:42 AM
12345678910...
//-->